Command Palette

Search for a command to run...

Beryl Drugs Ltd.
22.5(-4.26%)
1W: +5.67%

Beryl Drugs Peer Comparison

Snapshot Summary

Beryl Drugs Ltd. significantly lags behind its peers in terms of growth, profitability, and valuation metrics. Companies like Cipla Ltd. and Dr. Reddy's Laboratories Ltd. exhibit strong profitability and growth, while Beryl shows no positive growth metrics and a high PE ratio compared to its peers. This positions Beryl as an underperformer in the Pharmaceuticals & Drugs sector.

  • Beryl Drugs Ltd. shows zero revenue growth and no profitability metrics, making it a clear underperformer.
  • Cipla Ltd. and Dr. Reddy's Laboratories Ltd. stand out as top performers with strong revenue growth and profitability ratios.
  • Companies like Sun Pharmaceutical Industries Ltd. and Divi's Laboratories Ltd. exhibit high valuations but vary in growth rates and profitability.
  • Cipla Ltd.: Strong revenue growth (13.28% YoY) and solid profitability with a PE of 23.73 and ROE of 16.63%.
  • Dr. Reddy's Laboratories Ltd.: Offers a balanced combination of growth (16.54% YoY) and low valuation metrics with a PE of 15.50.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
Beryl Drugs Ltd.₹26.50₹13.44Cr23.21--
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.